Information for faculty and researchers

For information about remote work and other HR-related policies, visit the Information for Employees page.

Learning continuity

Open All Tabs
  • Using Blackboard: Helpful tips for faculty

    Please review these helpful tips for using Blackboard, developed specifically for faculty.

  • Copyright guidance

    As we move to teaching online during this extraordinary time, all instructional personnel must consider copyright issues raised by making certain materials available digitally. Please review the general copyright guidance from the Office of the Provost.

  • Supporting students with disabilities in online learning

    Our current situation is unprecedented, and it is with your support that we will be able to ensure academic continuity for our students. Below is information to assist in this regard.

    Accommodation Request Process

    Under the ADA, the University must make reasonable attempts to ensure online/remote/distance learning courses are accessible to individuals with disabilities. The process for requesting accommodations remains the same: 

    • Students have the responsibility to self-disclose and request accommodations through the Office of Disability Services.

    • Each student with approved accommodations must present the Professor Memo to faculty with fair notice prior to needing or using the accommodation.

     

    Types of Accommodations

    Below are some common accommodations along with recommendations to meet accommodation requests in an online/remote/distance learning environment.

    Testing Accommodations

    1.  Extended Time on exams - This accommodation will continue to apply for any timed assessments administered virtually. This does not apply to papers, projects, or longer take home exams.  Any exam hosted in Blackboard allows the time limit to be adjusted per student to allow for different stop times. 
     
    Instructions on extending exam time in Blackboard:
    • Go to Test Options
    • Go down to Test Availability
    • Add Users by clicking to download all students on the class roster
    • Select the students with extended time
    • Adjust the amount of minutes in the box next to their name.
     
    2.  Distraction Reduced testing location - It is up to the student to identify a location that minimizes distractions before starting an exam.
     
    3.  Use of computer - Online/remote/distance learning courses inherently use the computer and further coordination by the professor is not necessary.
     
    4.  Assistive Technology - This accommodation allows for the use of specialized equipment to augment a student’s hands or control of the mouse. Students with these accommodations were already using specialized equipment through the Office of Disabilities and will have access to this same equipment by using their own computer or equipment.  This is a very small group of students and in most cases, will not require faculty to make any adjustments to their course. 

     

    Other Accommodations

    1.  Screen Magnification - Blackboard is compatible with most vision assistive technology software used by individuals with a vision impairment. Examples include using screen reader software or screen magnification software.  Faculty with students who have been granted screen magnification assistive technology should be in touch with the Office of Disability Services as soon as possible.   
     
    2.  Video Captioning - This provides a written transcript of any lectures or videos for students with hearing impairments. UMIT has enabled this feature at the University level for Zoom videos.  For students with hearing impairments, the Office of Disabilities is coordinating captioning via a remote captioning transcription vendor and will continue these services.  Any faculty receiving a request for captioning of their course content should direct students to the Office of Disability Services as soon as possible.     
     
    3.  Communication disorders - Students who struggle with written communication may have difficulty expressing questions or ideas through writing. The virtual teaching environment can rely heavily on strong writing skills.  To help these students, faculty can offer a variety of communication methods that include email, phone calls, or video chats.  Offering these options will make sure students with written communication deficits are not at a disadvantage in the online learning environment. 

     

    Other Suggestions

    Professors can do the following to make online content accessible to all students:

    1.  Closed caption or a text transcription for video content, audio files, or course lectures.
     
    2.  A written transcription and general description for photos and graphics displayed in course material.
     
    3.  A standard file format for all documents posted within a course.
     
    4.  A list of compatible file formats for documents accessed by link or uploaded by instructor.
     
    5.  PowerPoint presentations and graphics in standard colors, fonts, and high/low contrast colors for the visually impaired.

     

    Communication About Accommodations

    Engaging in a conversation about a disability can be challenging via email.  A few things can make this easier for students:

    • Include a statement in your syllabus that students must follow the same process of notifying you 7 days prior to an exam if they intend on using their accommodations for any online tests/quizzes.
    • The policy should be advertised and posted in the course management system, Blackboard.
    • Instructors teaching online/remote/distance courses should communicate with students via phone to discuss more personal matters related to a disability.

     

    Unique Circumstances

    There may be specific accessibility issues that are not defined by the ADA because they are unique to an individual’s condition. Faculty should direct these students to the Office of Disabilities where our team will review the request and determine reasonable accommodations on a case-by-case basis.

    If you or your students have any questions or concerns related to accommodations please email disabilityservices@miami.edu.  Our team is here to provide support for students and faculty.

  • Learning continuity tools and resources

    The Academic Continuity Guide provides options for faculty to teach and support students in times of disruption, and aims to complement administrative and departmental guidelines.

Research continuity

Open All Tabs
  • Office of Research Administration COVID-19 announcements (Ongoing updates)

    The Office of Research Administration is sharing regular updates from federal and other regulatory agencies. Visit the office's COVID-19 announcements page.

  • Guidelines for performing critical research (March 18, 2020)

    Guidelines for performing critical research

    Updated 3/18/2020

    Acknowledgement: These guidelines are modified from those originally written by the University of Louisville.

    These guidelines are designed to help researchers adapt to the current viral pandemic while performing critical research activities.

    When people have to be in the laboratory, flexible non-overlapping shift schedules (different times of day and days of the week) should be used, when safety permits.

    Follow strict social distancing (maintain interpersonal distance of at least 6 ft.) and decontamination guidelines (listed below).

    Lab members will come to the lab for the purposes of continuing the essential lab and animal work only. Hand washing will be done each and every time a person enters or exits the lab for any reason. Only one person will be allowed in the tissue culture room at a time. No groups of individuals eating lunch together in the break room or congregating in building. No more than two individuals in the break room at a time.

    Perform non-laboratory-based work remotely (data analysis, manuscript revisions). All data can be saved and all writing done in appropriate group drives. No computer work should be done on personal computers in the lab.

    No in-person group lab meetings until further notice; all meetings should be held via phone or internet video conferencing.

    Personnel are advised to follow decontamination guidelines below:

    • Leave doors open when possible and limit the use of doorknobs.
    • Clean your phone/cellphone and do not take your cell phone with you to the restroom. Do not leave your phone on surfaces that are in common use.
    • Do not share pens/pencils. Carry a pen with you for your own use.
    • If you need to use a keyboard, other than your own, clean it (as well as the mouse), before and after you use it.
    • If you are using shared equipment clean off the knobs, handles etc.
    • Sneeze/cough into your elbow
    • Do not reuse tissues; dispose of immediately after single use and wash your hands (preferred) or use hand sanitizer.
    • Use an elbow or a knuckle on elevator or other buttons and leave the light switches on.
    • Use the automatic door openers (elbow or knuckle); do not use railings in the staircases.
    • Reduce or eliminate the use of headphones, iPod and cell phones. At home, clean your remote controls.
    • Wear disposable gloves to reduce your propensity to touch your face.
    • Do not share lab coats and do not pile used lab coats up with clean ones. Have your lab coats laundered professionally.
    • Do not put on Chap Stick or makeup outside of your home.
    • Wash your hands, even when you think you do not need to do so.

  • Information regarding virtualized research software (March 18, 2020)

    Researchers have access to virtual labs for applications such as Maple, Mplus, SPSS, and Stata – see details below:

    UMIT, in partnership with the School of Communication and the Richter Library, have engaged in the creation of a virtual environment for students. Currently, four applications have been virtualized: Maple, Mplus, SPSS, and Stata. To learn more, visit: vlabs.it.miami.edu

  • Guidance for on-campus research/scholarly activities (March 17, 2020)

    COVID-19 PANDEMIC: GUIDANCE FOR ON-CAMPUS RESEARCH/SCHOLARLY ACTIVITIES

    Updated March 17, 2020

    All faculty, staff, and postdoctoral fellows of the University of Miami (UM) should begin to work remotely where possible by Friday, March 20, 2020 at the latest. Graduate student research assistants (RAs), should begin to work remotely as soon as they return from Spring Break. Please note that this is not a closure of the University, but is intended for UM faculty, staff, RAs, and postdoctoral fellows to be able to continue critical functions while minimizing the spread of the coronavirus. This communication is a follow-up to the email sent last week requesting advance planning by the research community, to accommodate this rapidly evolving situation. 

    At this time, all researchers should implement plans to move to remote work, where possible. Below we provide the latest guidance and our expectations concerning this research/scholarship hiatus.

    All research laboratories and campus facilities engaged in research/scholarly activity should ramp down ongoing on-campus work, and delay initiating anything new. Research with SARS-CoV-2, COVID-19 and related activities should continue. All other critical research activities, including those involving human subjects, need to be communicated to the Dean, Vice President/Provost, or Chair/Division Chief/Center Director, in charge of the unit for review. Examples of critical activities include, but are not limited to, maintaining/freezing unique cell lines, maintaining instruments that can’t be easily shut down, maintaining animal populations, and/or other work for which stopping or delaying could cause a critical loss of animals/materials/data or pose risk to human subject well-being. No new on-campus research activities should be started until further notice. Deans, Chairs/Division Chiefs/Directors and VPs are asked to develop a list of the work in their units that they believe is critical for continuation on campus during this time period. Deans at the Coral Gables and RSMAS campuses should send these documents via email to Dr. John Bixby, Vice Provost for Research, by March 20th, 2020. Miller School Chairs/Division Chiefs/Directors should send them to Dr. Carl Schulman, Executive Dean for Research. Dr. Bixby will lead an assembled team of faculty and other research leadership to oversee the approval process for continuation of activities that are deemed critical.

    It is NOT intended that non-critical research/scholarly activities should stop; indeed, those that can be carried out remotely (planning, writing, literature review, remote data collection, data analysis, remote meetings, etc.) should continue during this time.

    All investigators, including research laboratories, should immediately implement the following plans:

    1.  RAs and postdoctoral fellows should communicate with their supervisors and/or research mentors about obtaining approval for critical research activities as defined above. Plans should include arrangements that help to ensure the safety of the individuals required for those activities to continue.

    2.  Implement approaches to maintain critical research/scholarship functions while protecting both the health of researchers and of research participants, which may include strategies for de-densifying personnel (i.e., social distancing), scheduling shift work when possible, and implementing operating procedures to mitigate spread of the virus, including, for example, frequent hand washing and routine cleaning of all work surfaces.

    3.  Firm up plans for each laboratory and/or research group to continue work under a potentially long-term (6-8 week) remote requirement. Currently, we are working with a mid-April timeline for relaxing this requirement but planning for a longer-term shutdown should be part of your preparations.

    4.  Clinical studies should follow the guidance set forth by the Human Subject Research Office; see March 17 guidance at https://coronavirus.miami.edu/.

    The research community can find additional resources and guidance from federal agencies and the University at https://coronavirus.miami.edu/.

    Questions should be addressed to Dr. Bixby at JBixby@med.miami.edu or Dr. Schulman at CSchulman@med.miami.edu.

  • Interim guidelines for human subjects-related research visits during the COVID-19 outbreak (March 17, 2020)

    Interim University of Miami Guidelines for Human Subjects-Related Research Visits During the COVID-19 Outbreak

    Background

    The University of Miami (UM) is implementing this guideline to protect research participants, researchers, and the larger South Florida community from risk of infection with the virus that causes COVID-19 as well as to ensure ongoing access to research, which may provide essential support and care to participants. This guideline will be revised as needed, based on new information, and circulated to the UM research community. It will also be available on the UM coronavirus website. Please send questions and comments on this guideline to hsro@miami.edu.

     

    Interim Guidance (Effective March 17th, 2020)

    Participants

    In-person interactions and interventions (visits) with research participants should be performed remotely, whenever possible.

    If you can obtain the data you need via the telephone, you should use the phone. If you need face-to-face time with a research subject in a clinical trial, consider asking them to register in MyChart and use the Epic telemedicine in MyChart.

    You can also use Zoom for Healthcare for face-to-face visits. Zoom is a video conferencing tool that combines an easy-to-use interface with exceptional video quality for collaboration across mobile devices, desktops, and conference rooms. There are two versions of Zoom. To access this HIPAA-compliant form of ZOOM, contact the TeleHealth team by emailing telehealth@miami.edu.

    If you will be discussing health information during these remote interactions, you should not use FaceTime, Skype, Skype for Business), Microsoft Teams, or the non-HIPAA-compliant Zoom.

    For visits that do not involve collection of health information, you can use the version of Zoom that is not HIPAA compliant. To activate your University of Miami account and download Zoom, visit zoom.miami.edu and sign in using your CaneID credentials. Once you sign in, that's it—you have activated your account. Download the Zoom Desktop at: miami.zoom.us/support/download. To learn how to download the Zoom desktop client and learn more about feature available for the University community, review the Zoom at the U Quick Start Guide.

    Nonessential Research Visits (see examples below)

    Until further notice, you should postpone visits that are not essential to a participant's health and/or well-being when you cannot perform the visit remotely. The determination of whether or not the research visit is "essential to the health and/or well-being” of the participant should be informed by the principal investigator of the study, the participant, the participant’s care provider (where appropriate), and should be informed by current public health guidance regarding the COVID-19 outbreak.

    Essential Research Visits (see examples below)

    If you cannot perform a research visit that is essential to a participant's health and/or well- being remotely, you can perform the visit in-person, with the following additional guidance:

    a)  Participants should be provided with information regarding the current COVID-19 epidemic and how best to reduce their risk of infection. You can provide this information in multiple forms suited to the type of contact, including a website link, a telephone script and an in-person If possible, you should share this before the research visit. See the following CDC COVID-19 link for reference and materials: https://www.cdc.gov/coronavirus/2019-ncov/index.html.

     

    b)  Research staff should verbally screen all research participants via phone for fever, cough, and flu-like symptoms before the research visit, if Research staff should re-screen participants when they arrive for the in-person visit.

     

    Participants who screen positive will require triage according to your institution’s clinical screening and triage protocols. If you are conducting research in an area that does not have a screening and triage protocol, you should comply with the University of Miami’s protocol.

     

     

    Jackson Health Systems (requires JHS network access)

     

    Enrollment of new participants in a clinical trial or other human subject-related research should be allowed only if:
    • Participation in the trial is essential to a participant's health and/or well-being, as determined as above; or
    • The enrollment and longitudinal participant management can be conducted remotely for the duration of the COVID-19 outbreak.

     

    Research Personnel

    All study personnel (faculty, research staff, post-doctoral scholars and graduate students) should receive appropriate training regarding proper research participant screening (e.g., masking protocols) and participant triage should they encounter a research participant who is at risk for COVID-19 infection during an in-person research visit screening. Please refer to your institution’s clinical screening and triage protocols.

    Until further notice, track missed, remote, and out of window study visits due to COVID- 19 as protocol deviations on a Deviation Log and report the deviations to the IRB within 30 days.

    Study Sponsors

    Principal investigators or their designees should contact study sponsors to notify them of this guideline and make appropriate arrangements. You should postpone all sponsor visits for clinical trials or other human subject-related research, whether for site qualification, site initiation, or monitoring visits, whenever feasible. You should base considerations for remote monitoring on study needs and resource availability.

     


    When is a Study Visit "Essential to the health and/or well-being" for Human Subject Research Visits During the COVID-19 outbreak.

    The following examples are provided as a guide to help principal investigators, participants, and participant care providers determine the suitability of in-person research visits. These determinations and the balance of potential benefits and harms will vary by study objectives, target patient population, and may change as the COVID-19 outbreak evolves. The following examples are not intended to be comprehensive of all study types.

    For these study designs:

    Is the specific research visit "essential to the health and/or well- being" of the participant, thus supporting in-person visits?

     

    These visit types are LIKELY "essential" (supports an in-person visit)

    These visit types may or may not be "essential"

    (Support for in-person

    visit will depend on specifics of the study)

    These visit types are LIKELY not "essential" (does not support an in-person visit)

    Randomized controlled efficacy trial (e.g., phase IIb or III) of a potential drug or device or other intervention

    • New enrollments
    • Follow-ups

     

     

    Post-approval trial (e.g., phase IV) of a therapeutic drug, device, or other

    intervention to assess tolerability and/or long-term benefit

    • Follow-ups
    • New enrollments

     

    Early phase (e.g., phase I or IIa) pharmacodynamic, safety, tolerability or

    feasibility trial a potential drug or device or other intervention

    • Follow-ups
    • New enrollments

     

    Non-randomized interventional trial of a

    drug, device, or other intervention requiring safety monitoring

    • Follow-ups
    • New enrollments

     

    Randomized controlled efficacy trials of a social behavioral intervention.

     

     

    • New enrollments
    • Follow-ups

    Non-randomized interventional trial of a drug, device, or other intervention not requiring safety monitoring

     

    • New enrollments
    • Follow-ups

     

    Comparative effectiveness studies or other study types describing the natural

    history of a disease or other clinical Outcomes

     

    • Follow-ups
    • New enrollments

    Non-interventional qualitative study

     

     

    • New enrollments
    • Follow-ups
    Non-interventional study with collection of clinical data and/or biological specimens for future research

     

     

    • New enrollments
    • Follow-ups

  • List of critical research activities (March 17, 2020)

    List of Critical Research Activities 

    Dear Colleagues:

    I am writing to request your assistance in helping university leadership understand those research activities that you would identify as “critical”, since only those activities can be carried out under the current “remote research” guidelines. In this context, critical means activities or essential experiments, that if discontinued, would generate harm to human or animal subjects, create safety issues, and/or incur significant financial loss, substantial data loss, or both.

    I am requesting information about research activities of investigators in your area involving the following:

    • human subject safety and health;
    • animal subject safety and health;
    • potential damage, safety concerns, or critical maintenance issues related to physical facilities or equipment;
    • stored samples, artifacts, data preservation;
    • any other projects with “high consequence” impacts that should be brought to our attention.

     

    For each activity designated as critical, please provide investigator name, title, department, and school, the specific on-campus activities designated as critical, a brief rationale (see below), eProst or IACUC numbers [if applicable], the name(s) of the individual or individuals who will be carrying out the activities, the building and room numbers involved, and the expected time period of the critical activities (including an end date). Your responses, as well as other relevant information, will help guide campus-wide research and business continuity planning by the Office of the Provost and the Vice Provost for Research.

    Questions may be directed to jbixby@miami.edu or cschulman@med.miami.edu.  Thank you for your prompt attention and cooperation.

     

    John L. Bixby
    Vice Provost for Research

     

    Research Activities Potentially Qualifying as “Critical” (not exhaustive)

    (in each case, articulate rationale for specifying a particular category)

    Human subject research that cannot tolerate an interruption or delay without significantly endangering the progress and results of a research program or project

    Clinical studies that are critical to patient care and cannot be interrupted, for either treatment and/or ethical reasons. These include randomized controlled trials in which access to study drug is central to a patient’s clinical care.

    Collection of biospecimens that cannot be temporarily banked for later analysis without adversely affecting quality of care

    Animal research that cannot tolerate an interruption or delay without significantly endangering the progress and results of a research program or project

    Research animals requiring specialized food, water, treatment and/or medication

    Breeding of research animals that, if interrupted, would cause a major setback to a research program (consider whether any such breeding can be scaled down)

    Any equipment or infrastructure that requires periodic maintenance, care or supervision during a closure (consider whether supply of liquid N2, helium, CO2, dry ice, etc. will be required)

    Any stored samples, artifacts, and/or data preservation that requires in-person maintenance, care or supervision during a closure

    Any research involving SARS-CoV-2 or COVID-19

  • Guidance for laboratory research personnel (March 13, 2020)

    Guidance for Laboratory Research Personnel (March 13, 2020)

    This information is available in PDF format.

    We gratefully acknowledge our colleagues at Yale University and UC Berkeley, whose communications to their research communities strongly influenced our own.

    The World Health Organization has now declared the coronavirus outbreak a global pandemic, and Miami-Dade County has recorded its first confirmed case. We expect this outbreak to cause some degree of disruption to research activities. Research activities should continue as possible, as long as they are consistent with University guidance. Faculty and research staff should check the guidance frequently.

    Please continue to monitor coronavirus.miami.edu for the most updated information.

    Immediate Measures to Reduce Transmission of Infectious Disease

    To reduce the potential transmission of the coronavirus (or other infectious diseases-- colds flu, etc.) in the coming weeks, the university asks that all research labs take the following steps:

    • Require personnel who are feeling sick to stay homeuntil they no longer have symptoms.
    • Remind all personnel to practice recommended sanitary measures,including washing hands frequently, using hand sanitizer, avoiding touching their face, and covering coughs/sneezes with their elbows.
    • Explore and (where feasible) implement measures to reduce personnel density (“social distancing”) for lab/research staff.For example, increasing spacing between individuals where possible to >6 feet, having personnel come to the lab in shifts, allowing every other bench to be unoccupied.
    • Consider opportunities for lab personnel to work remotely -both to allow for social distancing, or in case they need to self-isolate on short notice. Have personnel test out remote setups before they are needed. The current recommended university platform is Microsoft Teams; other platforms (Skype, Zoom, Google Hangouts, etc) can be used if preferred and functional.
    • Increase routine disinfecting of laboratory and communal spaces, including lab benches and chairs, equipment, common rooms, door handles, desks, etc.
    • Consider attending university meetings via phone or videoconference. Additionally, most scientific conferences and other research community meetings are being cancelled or are permitting remote participation.
    • Consider cancelling or postponing field research trips, as they present unique risks because of shared housing, shared dining spaces, and challenges in “sending someone home” should they become ill during an extended trip.
    • Monitor and follow university guidelines regarding academic and personal travel, both internationally and domestically.

     

    Long Term Planning for “Research Continuity”

    Investigators and research managers should begin planning now, should it happen that research and campus operations need to continue with reduced or even remote staffing, if significant numbers of research staff or research support personnel become ill, or large- scale self-isolation is required. Any changes to research support unit operations will be communicated to all campuses.

    Note: In no event should researchers take materials other than laptops, data storage devices, or similar devices offsite (e.g., to their homes) as a way to promote research continuity during a curtailment. All essential research must continue within the confines of appropriate laboratory space.

    Assumptions to use for planning, should widespread COVID-19 communal transmission require campus support operations to be delivered remotely, or with reduced staffing due to illness. These are not guarantees, but are our best projections to date:

    • The safety and the good health of our research workforce and our research animals will remain our highest priority.
    • Assume that essential research infrastructure, such as power, air conditioning, and telecommunications, will be maintained.
    • Assume that research administration and support units, such as the Office of Research Administration (ORA), Office of Technology Transfer (OTT), Office of the Vice Provost for Research (OVPR), Human Subjects Research Office (HSRO), Disclosures & Relationship Management (DRM), Research Compliance & Quality Assurance (RCQA), Office of Research Compliance Committees (IACUC, IBC, ESCRO), the Division of Veterinary Resources (DVR), and Environmental Health & Safety (EHS) will continue to provide services as required. These services may be slower and/or reduced in scope if the situation changes substantially.

     

    Nevertheless, investigators should plan for the following possibilities:

    • Be prepared for the possibility that some of your laboratory workforce to fall ill or be required to self-isolate.
    • Be prepared to decontaminate the workspace of an ill researcher in your laboratory.
    • Be prepared for core facilities and other fee-for-service resources to become slow, reduced in scope, or unavailable.
    • Be prepared for critical supply orders to be delayed. Investigators should work with their unit leadership and/or building managers to coordinate essential deliveries.
    • Be prepared for building or laboratory access to be curtailed, but not eliminated. The university will notify the affected communities as soon as Assume that essential access for equipment maintenance and critical laboratory experiments will continue. Such access will be coordinated through Building Managers. Review your list of essential personnel.
    • Be prepared that repairs performed by Facilities Services and other campus and non-campus service providers may be delayed.
    • Be prepared that processing of visas by the federal government may be delayed, resulting in delayed appointments.

     

    Steps you can take now to ensure continuity of critical functions in case of a severe outbreak:

    • Identify procedures and processes that require regular personnel attention (e.g., cell culture maintenance, animal studies).
    • Assess and prioritize critical laboratory activities. Create an accurate inventory of laboratory chemicals and sensitive laboratory instrumentation and equipment, and share this information with your building manager and EHS.
    • Identify any research experiments that can be ramped down, curtailed, or delayed.
    • Identify key personnel able to safely perform essential activities to insure the continuity of your laboratory’s research capability.
    • Ensure that you have access to up-to-date email and telephone contact information for your critical staff.
    • Cross-train research staff to substitute for others who may be out sick or unable to come to work.
      • Ensure staff have the appropriate, up-to-date training.
      • Document critical step-by-step instructions for laboratory procedures.
      • Encourage all researchers to be familiar with each other’s work if an absence would threaten the loss of experiments (such as which cells need transferring to new media, etc.)
    • Coordinate with colleagues who have similar research activities to identify ways to ensure mutual support and coverage of critical activities.
    • Review contingency plans and emergency procedures with researchers and staff.
    • Maintain a sufficient inventory of critical supplies that may be impacted by global shipping delays. Inform your building manager if your lab relies on regularly- scheduled supplies such as liquid nitrogen, dry ice or helium. Coordinate those deliveries with building management.
    • Check any remote control monitoring devices for critical equipment (e.g., -80°C freezers, liquid nitrogen storage dewars, incubators).
    • Communicate significant planned absences and/or lab closures to unit business offices and other key administrative units.

     

    Other safety considerations: 

    • Ensure that individuals performing critical tasks have been adequately trained and understand whom to contact with technical or safety questions.
    • Avoid performing high-risk procedures alone. When working alone is necessary, exercise extreme caution.
    • Ensure that research team members notify colleagues of their schedule when working alone for an extended period of time.
    • Ensure that high-risk materials (radioactive, biohazards, chemicals) are properly secured.

  • Guidance for basic and clinical research operations (March 13, 2020)

    The Miller School of Medicine research leadership is continuing to monitor and evaluate research operations with regards to the COVID-19 situation. Please find preliminary guidance for basic and clinical research operations (single sign-on required).